Showing results (21-30 of 32) with videos related to
Sort By:
Pageof 4
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 13, 2026
Paramagnetic rim lesions on 7T MRI after autologous hematopoietic cell transplantationMoein Amin, Kunio Nakamura, Bhaskar Thoomukuntla, et al.Neuroimage|December 5, 2025
Efficient Whole-Brain Quantitative Magnetization Transfer Imaging at 3T Using Segmented EPI Readout with Variable Power Magnetization Transfer Pulses (EP-vpMT)Se-Hong Oh, Ken E Sakaie, Gawon Lee, et al.Multiple Sclerosis Journal - Experimental, Translational and Clinical|December 20, 2021
Clinical features and outcomes of COVID-19 despite SARS-CoV-2 vaccination in people with multiple sclerosisDeja R Rose, Ahmad Z Mahadeen, Alise K Carlson, et al.Neurology. Clinical Practice|July 10, 2020
Achieving effective patient and public involvement in international clinical trials in neurologyEmma C Tallantyre, Nikos Evangelou, Clare Bale, et al.Antioxidants & Redox Signaling|November 9, 2017
Modulators of Redox Metabolism in Head and Neck CancerXiaofei Chen, Jade Mims, Xiumei Huang, et al.Molecular and Cellular Biology|September 20, 2006
Tyk2 tyrosine kinase expression is required for the maintenance of mitochondrial respiration in primary pro-B lymphocytesRamesh Potla, Thomas Koeck, Joanna Wegrzyn, et al.Multiple Sclerosis Journal - Experimental, Translational and Clinical|April 7, 2018
Feasibility of mesenchymal stem cell culture expansion for a phase I clinical trial in multiple sclerosisSarah M Planchon, Karen T Lingas, Jane Reese Koç, et al.Stem Cells Translational Medicine|July 13, 2016
Human Mesenchymal Stem Cells Impact Th17 and Th1 Responses Through a Prostaglandin E2 and Myeloid-Dependent MechanismAyal Rozenberg, Ayman Rezk, Marie-Noëlle Boivin, et al.Contemporary Clinical Trials|April 23, 2020
Determining the effectiveness of early intensive versus escalation approaches for the treatment of relapsing-remitting multiple sclerosis: The DELIVER-MS study protocolDaniel Ontaneda, Emma C Tallantyre, Praneeta C Raza, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|April 7, 2017
Pilot trial of intravenous autologous culture-expanded mesenchymal stem cell transplantation in multiple sclerosisJeffrey A Cohen, Peter B Imrey, Sarah M Planchon, et al.Pageof 4